-
Murray and colleagues provide a rigorous description of child mortality in 187 nations of the world.
-
-
A number of reports on dengue have been published recently in the Morbidity and Mortality Weekly Report. The CDC described dengue surveillance in the United States using two sources of data: 1) specimens tested at the CDC Dengue Branch (CDCDB); and 2) the ArboNET surveillance system of the CDC Arboviral Diseases Branch.
-
In this issue: Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
Research institutions increasingly are turning to central IRBs for multisite clinical trials, and this trend probably will accelerate due to recent news that federal regulators are encouraging the change, experts say.
-
Based on a survey of research participants, the office of research compliance and quality improvement at Cedars-Sinai Medical Center in Los Angeles, CA, has come up with these four key areas to demonstrate informed consent.
-
When the federal Office of Human Research Protections raised questions about a quality improvement (QI) initiative to reduce catheter infections in Michigan hospitals in 2007, it reignited a debate over the line between QI and human subjects research necessitating IRB review.
-
-
The Office for Human Research Protections (OHRP) in Washington, DC, is indicating to research institutions that the agency favors the use of centralized IRBs for multisite studies.
-
The Office for Human Research Protections (OHRP) in Washington, DC, recently published letters that explain the agency's revised stand on the use of central or external IRBs.
